Long Guo, Shen Junyi, Zhou Ledu
Department of Liver Surgery, Xiangya Hospital, Central South University, Changsha, China.
Department of Liver Surgery & Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, China.
Front Oncol. 2020 Aug 7;10:1286. doi: 10.3389/fonc.2020.01286. eCollection 2020.
The study aimed to investigate the clinical significance of preoperative alpha-fetoprotein (AFP) and gamma-glutamyl transferase (GGT) (A-G score) on hepatocellular carcinoma (HCC) patients. A total of 474 solitary HCC patients were included. Survival analysis was evaluated by Kaplan-Meier method. Prognostic factors were analyzed in a multivariate model. The comparison of the predictive value of AFP, GGT, and A-G score was performed by receiver operating characteristic curve (ROC) analysis and decision curve analysis (DCA). Of the 474 patients, 137(28.9%), 241(50.8%), and 96(20.3%) patients were assigned to A-G score 0, 1, and 2, respectively. In multivariate analysis, A-G score, tumor size, microvascular invasion, tumor differentiation, satellite lesion, and state of HBV infection were independently predictive factors for RFS of solitary HCC patients. The A-G score could significantly stratify solitary HCC patients with a distinguished prognosis. The 1-, 3-, and 5-year RFS and OS among patients with A-G score 1 was better than that of patients with A-G score 2 and worse than that of patients with A-G score 0(all < 0.05). Based on the result from the ROC analysis and DCA analysis, the A-G score appeared to be superior to either AFP or GGT alone in the prediction of prognosis of solitary HCC patients. In the subgroup analysis, the A-G score could accurately predict the prognosis of solitary HCC patients without MVI or with liver cirrhosis. Preoperative A-G score could effectively and simply predict prognosis of solitary HCC patients after hepatectomy, especially for those with non-MVI solitary HCC or those with liver cirrhosis.
该研究旨在探讨术前甲胎蛋白(AFP)和γ-谷氨酰转移酶(GGT)(A-G评分)对肝细胞癌(HCC)患者的临床意义。共纳入474例孤立性HCC患者。采用Kaplan-Meier法进行生存分析。在多变量模型中分析预后因素。通过受试者工作特征曲线(ROC)分析和决策曲线分析(DCA)对AFP、GGT和A-G评分的预测价值进行比较。在474例患者中,分别有137例(28.9%)、241例(50.8%)和96例(20.3%)患者被分配到A-G评分0、1和2组。多变量分析显示,A-G评分、肿瘤大小、微血管侵犯、肿瘤分化、卫星灶和HBV感染状态是孤立性HCC患者无复发生存期(RFS)的独立预测因素。A-G评分可显著区分孤立性HCC患者的预后。A-G评分为1的患者1年、3年和5年的RFS及总生存期(OS)均优于A-G评分为2的患者,且差于A-G评分为0的患者(均P<0.05)。基于ROC分析和DCA分析结果,A-G评分在预测孤立性HCC患者预后方面似乎优于单独的AFP或GGT。亚组分析显示,A-G评分可准确预测无微血管侵犯(MVI)或合并肝硬化的孤立性HCC患者的预后。术前A-G评分可有效且简单地预测肝切除术后孤立性HCC患者的预后,尤其是对于无MVI的孤立性HCC患者或合并肝硬化的患者。